Cedars-Sinai Cancer: Neoadjuvant Approach to Oncology Spring Conference 2026

Saturday, May 9, 2026, 7:30 AM - 2:00 PM PT, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA


The Neoadjuvant Approach to Oncology Conference is a multidisciplinary educational activity designed to examine the evolving role of neoadjuvant therapies across multiple cancer types. As advances in systemic treatments, biomarkers, and imaging continue to reshape oncology care, neoadjuvant strategies are increasingly used to improve surgical outcomes, assess treatment response, and personalize therapy.

1. Apply current evidence and guidelines to select appropriate patients for neoadjuvant therapy based on tumor biology, molecular and immune biomarkers, imaging findings, and patient specific factors
2. Integrate novel systemic therapies, including immunotherapy and targeted agents, into neoadjuvant treatment plans while appropriately managing treatmentrelated and immunemediated toxicities.
3. Use AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence based national guidelines for treatment planning.
4. Collaborate effectively within a multidisciplinary care team to coordinate neoadjuvant treatment delivery, optimize surgical timing, and ensure seamless transitions between phases of care.

All Healthcare Providers - $0.00

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (6.00 hours), Non-Physician AMA Attendance (6.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, May 9, 2026